Descrição
Reference list and supplementary information from the clinical trial evaluating Bacillus coagulans MTCC 5856 in diarrhea-predominant irritable bowel syndrome. This section documents the supporting literature cited throughout the study.
Figure 4
Source Paper
Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled …Cite This Figure
![Figure 4: Reference list and supplementary information from the clinical trial evaluating Bacillus coagulans MTCC 5856 in diarrhea-predominant irritable bowel syndrome. This section documents the supporting literature cited throughout the study.]() > Source: Muhammed Majeed et al. "Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predo." *Nutrition journal*, 2016. PMID: [26922379](https://pubmed.ncbi.nlm.nih.gov/26922379/)
<figure> <img src="" alt="Reference list and supplementary information from the clinical trial evaluating Bacillus coagulans MTCC 5856 in diarrhea-predominant irritable bowel syndrome. This section documents the supporting literature cited throughout the study." /> <figcaption>Figure 4. Reference list and supplementary information from the clinical trial evaluating Bacillus coagulans MTCC 5856 in diarrhea-predominant irritable bowel syndrome. This section documents the supporting literature cited throughout the study.<br> Source: Muhammed Majeed et al. "Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predo." <em>Nutrition journal</em>, 2016. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/26922379/">26922379</a></figcaption> </figure>